Literature DB >> 30366153

Two distinct aggregation pathways in transthyretin misfolding and amyloid formation.

Anvesh K R Dasari1, Ivan Hung2, Zhehong Gan2, Kwang Hun Lim3.   

Abstract

Misfolding and amyloid formation of transthyretin (TTR) is implicated in numerous degenerative diseases. TTR misfolding is greatly accelerated under acidic conditions, and thus most of the mechanistic studies of TTR amyloid formation have been conducted at various acidic pH values (2-5). In this study, we report the effect of pH on TTR misfolding pathways and amyloid structures. Our combined solution and solid-state NMR studies revealed that TTR amyloid formation can proceed via at least two distinct misfolding pathways depending on the acidic conditions. Under mildly acidic conditions (pH 4.4), tetrameric native TTR appears to dissociate to monomers that maintain most of the native-like β-sheet structures. The amyloidogenic protein undergoes a conformational transition to largely unfolded states at more acidic conditions (pH 2.4), leading to amyloid with distinct molecular structures. Aggregation kinetics is also highly dependent upon the acidic conditions. TTR quickly forms moderately ordered amyloids at pH 4.4, while the aggregation kinetics is dramatically reduced at a lower pH of 2.4. The effect of the pathogenic mutations on aggregation kinetics is also markedly different under the two different acidic conditions. Pathogenic TTR variants (V30M and L55P) aggregate more aggressively than WT TTR at pH 4.4. In contrast, the single-point mutations do not affect the aggregation kinetics at the more acidic condition of pH 2.4. Given that the pathogenic mutations lead to more aggressive forms of TTR amyloidoses, the mildly acidic condition might be more suitable for mechanistic studies of TTR misfolding and aggregation.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid formation; Misfolding; Solid-state NMR; Transthyretin

Mesh:

Substances:

Year:  2018        PMID: 30366153      PMCID: PMC6339575          DOI: 10.1016/j.bbapap.2018.10.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  34 in total

Review 1.  Conformational constraints for amyloid fibrillation: the importance of being unfolded.

Authors:  Vladimir N Uversky; Anthony L Fink
Journal:  Biochim Biophys Acta       Date:  2004-05-06

2.  S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril.

Authors:  Toyofumi Nakanishi; Masanori Yoshioka; Kazuyoshi Moriuchi; Daisuke Yamamoto; Motomu Tsuji; Takayuki Takubo
Journal:  Biochim Biophys Acta       Date:  2010-04-10

3.  Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.

Authors:  Kwang Hun Lim; Anvesh K R Dasari; Renze Ma; Ivan Hung; Zhehong Gan; Jeffery W Kelly; Michael C Fitzgerald
Journal:  Biochemistry       Date:  2017-08-30       Impact factor: 3.162

4.  A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.

Authors:  Tiago Q Faria; Zaida L Almeida; Pedro F Cruz; Catarina S H Jesus; Pedro Castanheira; Rui M M Brito
Journal:  Phys Chem Chem Phys       Date:  2015-03-21       Impact factor: 3.676

Review 5.  Transthyretin mutations in health and disease.

Authors:  M J Saraiva
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

6.  Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

Authors:  W Colon; J W Kelly
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

7.  Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.

Authors:  Per Hammarström; Xin Jiang; Amy R Hurshman; Evan T Powers; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-25       Impact factor: 11.205

8.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

9.  The beta-strand D of transthyretin trapped in two discrete conformations.

Authors:  Andreas Hörnberg; Anders Olofsson; Therese Eneqvist; Erik Lundgren; A Elisabeth Sauer-Eriksson
Journal:  Biochim Biophys Acta       Date:  2004-07-01

10.  Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils.

Authors:  Minna Groenning; Raul I Campos; Daniel Hirschberg; Per Hammarström; Bente Vestergaard
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

View more
  3 in total

1.  Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin.

Authors:  Mateusz Banach; Katarzyna Stapor; Piotr Fabian; Leszek Konieczny; Irena Roterman
Journal:  Entropy (Basel)       Date:  2021-04-13       Impact factor: 2.524

2.  Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo.

Authors:  Anvesh K R Dasari; Ivan Hung; Brian Michael; Zhehong Gan; Jeffery W Kelly; Lawreen H Connors; Robert G Griffin; Kwang Hun Lim
Journal:  Biochemistry       Date:  2020-04-30       Impact factor: 3.162

3.  Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.

Authors:  Shuangyan Zhou; Jie Cheng; Ting Yang; Mingyue Ma; Wenying Zhang; Shuai Yuan; Glenn V Lo; Yusheng Dou
Journal:  Biomolecules       Date:  2019-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.